Literature DB >> 30500291

Data Set for the Reporting of Nodal Excisions and Neck Dissection Specimens for Head and Neck Tumors: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting.

Martin J Bullock1, Jonathan J Beitler1, Diane L Carlson1, Isabel Fonseca1, Jennifer L Hunt1, Nora Katabi1, Philip Sloan1, S Mark Taylor1, Michelle D Williams1, Lester D R Thompson1.   

Abstract

Standardized, synoptic pathologic reporting for tumors greatly improves communication among clinicians, patients, and researchers, supporting prognostication and comparison about patient outcomes across institutions and countries. The International Collaboration on Cancer Reporting is a nonprofit organization whose mission is to develop evidence-based, universally available surgical pathology reporting data sets. Within the head and neck region, lymph node excisions and neck dissections are frequently performed as part of the management of head and neck cancers arising from the mucosal sites (sinonasal tract, nasopharynx, oropharynx, hypopharynx, oral cavity, and larynx) along with bone tumors, skin cancers, melanomas, and other tumor categories. The type of specimen, exact location (lymph node level), laterality, and orientation (by suture or diagram) are essential to accurate classification. There are significant staging differences for each anatomic site within the head and neck when lymph node sampling is considered, most importantly related to human papillomavirus-associated oropharyngeal carcinomas and mucosal melanomas. Number, size, and site of affected lymph nodes, including guidelines on determining the size of tumor deposits and the presence of extranodal extension and soft tissue metastasis, are presented in the context of prognostication. This review elaborates on each of the elements included in the data set for Nodal Excisions and Neck Dissection Specimens for Head & Neck Tumours.

Entities:  

Mesh:

Year:  2018        PMID: 30500291     DOI: 10.5858/arpa.2018-0421-SA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

Review 1.  Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology.

Authors:  Travis C Salzillo; Nicolette Taku; Kareem A Wahid; Brigid A McDonald; Jarey Wang; Lisanne V van Dijk; Jillian M Rigert; Abdallah S R Mohamed; Jihong Wang; Stephen Y Lai; Clifton D Fuller
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

2.  Histopathological Definitions of Extranodal Extension: A Systematic Review.

Authors:  Chadi Nimeh Abdel-Halim; Tine Rosenberg; Stine Rosenkilde Larsen; Poul Flemming Høilund-Carlsen; Jens Ahm Sørensen; Max Rohde; Christian Godballe
Journal:  Head Neck Pathol       Date:  2020-09-12

3.  Differential expression of podoplanin in metastatic lymph node is associated with extranodal extension in oropharyngeal cancer.

Authors:  Hye Ran Lee; Jin Roh; Ga Young Gu; Ju Ho Lee; Yoo Seob Shin; Jeon Yeob Jang; Chul-Ho Kim
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

4.  [De-escalation of adjuvant radiotherapy after transoral surgery of HPV-associated oropharyngeal cancer: results of the E3311 trial].

Authors:  Alexander Rühle; Nils H Nicolay
Journal:  Strahlenther Onkol       Date:  2022-02-08       Impact factor: 3.621

5.  Nodal characteristics associated with adverse prognosis in oral cavity cancer are linked to host immune status.

Authors:  Cristina Valero; Daniella K Zanoni; Anjali Pillai; Bin Xu; Nora Katabi; Ronald A Ghossein; Ian Ganly; Luc G T Morris; Jatin P Shah; Richard J Wong; Snehal G Patel
Journal:  J Surg Oncol       Date:  2020-09-24       Impact factor: 3.454

6.  Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation.

Authors:  Flora Yan; Hong Li; John R de Almeida; John M Kaczmar; Patrik Pipkorn; Joseph Zenga; Mary S Richardson; David M Neskey; Anand K Sharma; Terry A Day; Evan M Graboyes
Journal:  Otolaryngol Head Neck Surg       Date:  2021-02-23       Impact factor: 5.591

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.